MOUNTAIN VIEW, Calif., Feb. 8, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that Timothy E. Morris, chief financial officer, will present an overview of the company at three investment conferences during the month of February 2013.
A live webcast and 30-day archive of the presentations will be available at http://ir.vivus.com . About VIVUS VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health for U.S., Europe and other world markets. For more information about the company, please visit www.vivus.com . Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS' Form 10-K for the year ending December 31, 2011, and periodic reports filed with the Securities and Exchange Commission.
Leerink Swann 2013 Global Healthcare Conference February 13, 2013, 12:00 noon EST Waldorf Astoria Hotel New York, NY Citi Equities 2013 Global Healthcare Conference February 27, 2013, 11:05am EST Hilton New York New York, NY RBC Capital Markets Healthcare Conference February 27, 2013, 2:00pm EST New York Palace Hotel New York, NY
CONTACT: VIVUS, Inc. Timothy E. Morris Chief Financial Officer email@example.com Financial Media Relations: Joele Frank, Wilkinson Brimmer Katcher Eric Bonach firstname.lastname@example.org 212-355-4449 Investor Relations: The Trout Group Brian Korb email@example.com 646-378-2923